Blue Square Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Sell
14,937
-150
-1% -$51.3K 2.19% 15
2026
Q1
$5.31M Buy
15,087
+74
+0.5% +$26.4K 2.52% 16
2025
Q4
$4.91M Sell
15,013
-340
-2% -$108K 2.18% 19
2025
Q3
$4.33M Buy
15,353
+44
+0.3% +$12.8K 1.89% 22
2025
Q2
$4.27M Buy
15,309
+1,241
+9% +$352K 2% 18
2025
Q1
$4.38M Sell
14,068
-203
-1% -$59.9K 2.36% 14
2024
Q4
$3.72M Buy
14,271
+7,277
+104% +$2.16M 1.85% 17
2024
Q3
$2.25M Buy
6,994
+126
+2% +$41.2K 1.21% 29
2024
Q2
$2.15M Buy
6,868
+268
+4% +$78.7K 1.25% 29
2024
Q1
$1.88M Sell
6,600
-22
-0.3% -$6.44K 1.25% 26
2023
Q4
$1.91M Buy
6,622
+1,387
+26% +$378K 1.27% 22
2023
Q3
$1.41M Buy
5,235
+1,216
+30% +$303K 1.04% 29
2023
Q2
$892K Buy
4,019
+2,401
+148% +$557K 0.63% 57
2023
Q1
$391K Buy
+1,618
New +$397K 0.26% 60
2022
Q3
Sell
-4,133
Closed -$1.01M 31
2022
Q2
$1.01M Sell
4,133
-2,642
-39% -$647K 2.16% 11
2022
Q1
$1.64M Sell
6,775
-37
-0.5% -$8.5K 1.37% 20
2021
Q4
$1.53M Buy
6,812
+57
+0.8% +$12K 0.95% 31
2021
Q3
$1.44M Buy
6,755
+153
+2% +$35.2K 0.9% 34
2021
Q2
$1.61M Buy
6,602
+684
+12% +$168K 0.99% 26
2021
Q1
$1.47M Buy
5,918
+250
+4% +$59.7K 0.94% 27
2020
Q4
$1.3M Sell
5,668
-1,848
-25% -$426K 0.87% 31
2020
Q3
$1.91M Buy
7,516
+1,407
+23% +$349K 1.32% 19
2020
Q2
$1.44M Sell
6,109
-1,260
-17% -$287K 0.99% 25
2020
Q1
$1.49M Buy
7,369
+17
+0.2% +$3.71K 1.38% 19
2019
Q4
$1.77M Sell
7,352
-3,364
-31% -$742K 1.38% 17
2019
Q3
$2.07M Buy
+10,716
New +$2.06M 1.63% 14

Other funds holding AMGN

Blue Square Asset Management's AMGN Position: Q2 2026 in Review

Blue Square Asset Management reduced its Amgen (AMGN) stake by 0.99% in Q2 2026, selling an estimated $51.3K and leaving 14,937 shares worth $5.41M. The position accounts for 2.19% of the portfolio, ranked #15.

Blue Square Asset Management first reported a position in AMGN in Q3 2019 and has held it in 26 quarters since. 1,276 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Blue Square Asset Management held 14,937 shares of Amgen worth $5.41M as of Q2 2026.
  • Blue Square Asset Management sold 150 Amgen shares in Q2 2026, an estimated $51.3K.
  • Amgen made up 2.19% of Blue Square Asset Management's portfolio in Q2 2026, its #15 holding.
  • Blue Square Asset Management first reported a position in Amgen in Q3 2019 and has held it in 26 quarters since.
  • 1,276 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Blue Square Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.